Accueil > Actualité
Actualite financiere : Actualite bourse

bioMérieux: CE marking of SARS-CoV-2 tests

( - bioMérieux today announces CE marking of VIDAS Anti-SARS-CoV-2 serological tests for the detection of antibodies in persons exposed to the SARS-CoV-2 virus, which leads to the Covid-19 disease.

It points out that its two VIDAS anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG tests provide results in less than 30 minutes and have demonstrated excellent performance on a large number of clinical samples, with respective specificity of 99.4% and 99.9%.

The tests are now available in Europe and in countries that recognise CE marking. bioMérieux plans to quickly submit an application for emergency use of these tests to the FDA in the United States.

Copyright (c) 2020 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.